B-MoGen Biotechnologies is Biotechnology in United States that focus on gene editing business. Founded in 2015. They cover business area such as developer, genome engineering technology, gene delivery, gene editing, custom vector generation service, multi-gene expression vector, prove sleep beauty transposon system, transposase vector, unique research solution, disease model, cell, scientist, life-change medicine, human disease.
2015
( 9 years old in 2024 )
Gene Editing
-
1621 East Hennepin Avenue
Suite B-15
Minneapolis, MN 55414
United States
Private
developergenome engineering technologygene deliverygene editingcustom vector generation servicemulti-gene expression vectorprove sleep beauty transposon systemtransposase vectorunique research solutiondisease modelcellscientistlife-change medicinehuman disease
* We use standard office opening hours in near B-MoGen Biotechnologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
B-MoGen Biotechnologies is Biotechnology business from United States that founded in 2015 (9 years old in 2024), B-MoGen Biotechnologies business is focusing on Gene Editing.
B-MoGen Biotechnologies headquarter office and corporate office address is located in 1621 East Hennepin Avenue Suite B-15 Minneapolis, MN 55414 United States.
B-MoGen Biotechnologies was founded in United States.
In 2024, B-MoGen Biotechnologies is currently focus on gene editing sector.
Above is snippet of Google Trends for "gene editing" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with B-MoGen Biotechnologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
